Reported adverse events in young women following quadrivalent human papillomavirus vaccination

Journal of Women's Health

Volumn 21, Issue 4, 2012, Pages 425-432

  Naleway, Allison L ^a   Gold, Rachel ^a   Drew, Lois ^a   Riedlinger, Karen ^a   Henninger, Michelle L ^a   Gee, Julianne ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ATTITUDE; CANCER IMMUNIZATION; CANCER SUSCEPTIBILITY; CHILD; ELECTRONIC MEDICAL RECORD; FAMILY HISTORY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 4; INJECTION SITE CONTUSION; INJECTION SITE DISCOLORATION; INJECTION SITE PAIN; INJECTION SITE SWELLING; KNOWLEDGE; MAJOR CLINICAL STUDY; MANAGED CARE; PATIENT MONITORING; PRESYNCOPE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SYNCOPE; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; DENMARK; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84859801859     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.2895     Document Type: Review

References (42)

1. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson , Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56:1-24.
2. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010;59:626-629.
3. Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010;59:630-632.
4. Shefer A, Markowitz L, Deeks S, et al. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine 2008;26:K68-75.
5. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003;14:300-306. (Pubitemid 36606105)
6. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 2008;111:1103-1110. (Pubitemid 351620344)
7. Lenehan JG, Leonard KC, Nandra S, Isaacs CR, Mathew A, Fisher WA. Women's knowledge, attitudes, and intentions concerning human papillomavirus vaccination: Findings of a waiting room survey of obstetrics-gynaecology outpatients. J Obstet Gynaecol Can 2008;30:489-499.
8. Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health 2008;57:23-32.
9. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health 2007;7:304.
10. Scarinci IC, Garcés-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health 2007;16:1224-1233. (Pubitemid 47587338)
11. McClelland A, Liamputtong P. Knowledge and acceptance of human papillomavirus vaccination: Perspectives of young Australians living in Melbourne, Australia. Sex Health 2006;3:95-101. (Pubitemid 43829306)
12. Jain N, Stokley S, Yankey D. Vaccination coverage among adolescents aged 13-17 years, - United States, 2007. MMWR 2008;57:1100-1103.
13. Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adults, 2007. Prev Med 2009;48:426-431.
14. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. J Adolesc Health 2009;45:453-462.
15. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010;171:357-367.
16. Dorell C, Stokley S, Cohn A, Markowitz L. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR 2010;59:1018-1023.
17. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 2008;42:237-242.
18. Kollar LM, Kahn JA. Education about human papillomavirus and human papillomavirus vaccines in adolescents. Curr Opin Obstet Gynecol 2008;20:479-483.
19. Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: A systematic review. Prev Med 2008;46:87-98. (Pubitemid 351163310)
20. Lambert EC. College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract 2001;14:178-183. (Pubitemid 33606223)
21. Gerhardt CA, Pong K, Kollar LM, Hillard PJ, Rosenthal SL. Adolescents' knowledge of human papillomavirus and cervical dysplasia. J Pediatr Adolesc Gynecol 2000;13:15-20. (Pubitemid 30488720)
22. Ragin CC, Edwards RP, Jones J, et al. Knowledge about human papillomavirus and the HPV vaccine-A survey of the general population. Infect Agent Cancer 2009;4:S10.
23. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008;43:239-245.
24. Watts LA, Joseph N, Wallace M, et al. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol 2009; 112:577-1582.
25. Cates JR, Brewer NT, Fazekas KI, Mitchell CE, Smith JS. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. J Rural Health 2009;25:93-97.
26. Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer DL. HPV and cervical cancer testing and prevention: Knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res 2008;18:584-596. (Pubitemid 351546649)
27. Fazekas KI, Brewer NT, Smith JS. HPV vaccine acceptability in a rural Southern area. J Womens Health 2008;17:539-548. (Pubitemid 351630156)
28. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med 2007;45:107-114. (Pubitemid 47348081)
29. Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure. Pediatrics 2010;126:425-433.
30. Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H, McNutt L. Human papillomavirus vaccine uptake and barriers: Association with perceived risk, actual risk and race/ ethnicity among female students at a New York State university. Vaccine 2011;29:3138-143.
31. The FUTURE II Study Group. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. J Infect Dis 2007;196:1438-1446.
32. Gardasil-package insert. Whitehouse Station, NJ: Merck and Co., Inc.
33. Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance of quadrivalent human papillomavirus recombinant vaccine. JAMA 2009;302:750-757.
34. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 2001;345:99-106. (Pubitemid 32634569)
35. Centers for Disease Control and Prevention (CDC). Syncope after vaccination-United States, January 2005-July 2007. MMWR 2008;57:457-460.
36. Siddiqui MA, Perry CM. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs 2006;66:1263-1273.
37. Sandfort JR, Pleasant A. Knowledge, attitudes and informational behaviors of college students in regard to the human papillomavirus. J Am Coll Health 2009;58:141-149.
38. Brewer NT, Gottlieb SL, Reiter PL, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2011;38:197-204.
39. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine 2011;29:890-805.
40. Sax LJ, Gilmartin SK, Bryant AN. Assessing response rates and nonresponse bias in web and paper surveys. Res Higher Edu 2003;44:409-432.
41. Sax LJ, Gilmartin SK, Lee JJ, Hagedorn JS. Using web surveys to reach community college students: An analysis of response rates and response bias. Community Coll J Res Pract 2008;32:712-729.
42. Shiu TH, Fan X. Comparing response rates from web and mail surveys: A meta-analysis. Field Methods 2003;20:249-271.